Assessment of the Bioavailability of Iron in Iron Fortified Bouillon Cubes in Healthy Nigerian Women
NCT ID: NCT02815449
Last Updated: 2017-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2017-05-08
2017-07-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the current study adding different levels of a stabilizer to iron fortified cubes and it's effect on iron bioavailability from these cubes will be studied in the context of a Nigerian meal in women.
24 Female subjects with low serum ferritin levels will be included in the study. The study will last 64 days and subjects will be asked to consume a breakfast and lunch prepared with a bouillon cube with isotope labeled iron during 3 periods of 5 consecutive days. The absorption of iron will be evaluated after every period and compared between the cubes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Iron Bioavailability From Cubes
NCT02327299
Bioavailability of Iron From Savoury Food Product
NCT02280915
Fermented Iron-rich Supplement in Reducing Anemia
NCT02037724
Iron Bioavailability From Fortified Food
NCT02993835
Iron Bioavailability From Biofortified Orange-fleshed Sweet Potato
NCT03840031
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low stabilizer level
Meals prepared with iron fortified cube with low stabilizer level
Meals prepared with iron fortified cube with Low stabilizer level
Meals prepared with iron fortified cube with Low stabilizer level
Medium stabilizer level
Meals prepared with iron fortified cube with medium stabilizer level
Meals prepared with iron fortified cube with Medium stabilizer level
Meals prepared with iron fortified cube with Medium stabilizer level
High stabilizer level
Meals prepared with iron fortified cube with high stabilizer level
Meals prepared with iron fortified cube with High stabilizer level
Meals prepared with iron fortified cube with High stabilizer level
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Meals prepared with iron fortified cube with Low stabilizer level
Meals prepared with iron fortified cube with Low stabilizer level
Meals prepared with iron fortified cube with Medium stabilizer level
Meals prepared with iron fortified cube with Medium stabilizer level
Meals prepared with iron fortified cube with High stabilizer level
Meals prepared with iron fortified cube with High stabilizer level
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 and \<40 years at screening;
* Body weight \<65 kg;
* Apparently healthy: no medical conditions which might affect study measurements (judged by study physician);
* With iron deficiency judged by a serum ferritin concentration of \<15µg/L;
* Reported intense sporting activities ≤ 10h/w;
* Reported alcohol consumption ≤ 14 units/w;
* Willing and able to participate in the study;
* Having given a written informed consent.
Exclusion Criteria
* Blood donation or significant blood loss over the past 6 months;
* Being severely anemic (hemoglobin \< 8.0 g/dL)
* Reported use of any medically- or self-prescribed diet;
* Use of vitamin or mineral supplements and unwillingness to discontinue their use one week prior the study and during the study;
* Smoking or consuming tobacco in any form, and/or was smoking or consuming tobacco in any form for 6 months preceding the study and/or will be smoking or consuming tobacco in any form, during the study;
* Is pregnant or will be planning pregnancy during the study period;
* Is lactating or has been lactating in the 6 weeks before pre-study investigation and/or during the study period;
* Known gastrointestinal (including helminth infection) or metabolic disorders;
* Participation in another clinical trial during the last 30 days prior to the beginning of the study;
* Symptomatic malaria (no blood smear analyses on malaria required)
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Obafemi Awolowo University
OTHER
Unilever R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Funke Olumakaiye, PhD
Role: PRINCIPAL_INVESTIGATOR
Obafemi Awolowo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Obafemi Owalowo University
Ile-Ife, , Nigeria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Eilander A, Funke OM, Moretti D, Zimmermann MB, Owojuyigbe TO, Blonk C, Murray P, Duchateau GS. High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women. J Nutr. 2019 May 1;149(5):723-729. doi: 10.1093/jn/nxz003.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FDS-SAV-2103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.